Could cause temporary or reversible harm; serious harm is unlikely.
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
| Brand name | CHLORPROMAZINE HYDROCHLORIDE |
| Generic name | CHLORPROMAZINE HYDROCHLORIDE |
| Active ingredient(s) | CHLORPROMAZINE HYDROCHLORIDE |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 70710-1129-1 |
| Full product label | chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1 |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA |
| Quantity | 3144 bottles, pack size: 100's Count |
| Recall initiated | 2025-04-03 |
| Report date | 2025-04-16 |
| Recall completed | — |
| Recall number | D-0361-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗